Deep Learning Framework NeoPep Enables Accurate De Novo Design of Functional Peptides
Researchers have developed NeoPep, a generative deep-learning system capable of designing functional peptides de novo by encoding biophysical principles learned from over 5 million peptide-protein complexes. Tested across 10 diverse biological targets, the system achieved hit rates of 12.5–66.7% without requiring predefined binding sites or structural data. The advance could significantly accelerate drug discovery and bioengineering by reducing dependence on experimental structure determination.
NeoPep is a generative deep-learning framework developed to address a longstanding challenge in biochemistry: designing peptides from scratch that can reliably interact with target proteins. The system was trained on more than 5 million peptide-protein complexes drawn from experimentally determined structures, sequence mimics, and structural ensembles, allowing it to learn the nuanced biophysical rules governing peptide function. In prospective tests across 10 challenging biological targets, NeoPep produced potent binders, agonists, and antagonists with hit rates ranging from 12.5% to 66.7%, even when no binding site or structural information was provided. In a structure redesign mode, the system generated peptides with atomic-level conformational accuracy, achieving a Cα RMSD below 2.0 Å compared to experimentally solved cryo-EM structures. This precision eliminated the need for iterative experimental structure determination and enabled a 43.3-fold improvement in peptide potency through accelerated sequence redesign. The framework also supports standalone sequence or structure redesign and can discriminate subtle contextual differences between targets. The authors argue NeoPep establishes a generalizable pipeline for translating biophysical knowledge into functional peptide design with broad applications in medicine and bioengineering.
What's missing
As a preprint posted to bioRxiv, this work has not yet undergone formal peer review, and independent replication of the reported hit rates and potency improvements has not been established. The study does not fully detail the criteria used to define a 'hit' across all 10 targets, nor does it report the cost, timelines, or scalability of experimental validation. Long-term in vivo efficacy and safety of the designed peptides remain untested.
What different sources said
- bioRxivCenter
Accurate de novo design of peptides from programming biophysical landscape
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.